Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia (Q37406418)
Jump to navigation
Jump to search
scientific article published on 04 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia |
scientific article published on 04 September 2013 |
Statements
1 reference
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia (English)
1 reference
Young H Lim
Jeffrey S Sugarman
Cynthia M C Deklotz
Ann Maruri
Lawrence F Eichenfield
Patrick K Kelley
Michael Gottschalk
Cynthia J Tifft
Rachel I Gafni
Alison M Boyce
Edward W Cowen
Nisan Bhattacharyya
Lori C Guthrie
William A Gahl
Gretchen Golas
Erin C Loring
John D Overton
Shrikant M Mane
Richard P Lifton
Moise L Levy
Michael T Collins
Keith A Choate
1 reference
1 reference
1 reference
3 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference